Alteration in cerebrospinal fluid (CSF) markers associated with α-synucleinopathies


Rapid eye movement sleep behavior disorder (RBD) is linked to other α-synucleinopathies such as Parkinson’s disease and Lewy body dementia. It is essential to consider and exclude RBD while studying CSF markers in the latter two to avoid confounding bias and improve test results’ specificity.

This is a preview of subscription content, log in to check access.


  1. 1.

    Gmitterová K et al (2018) Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia. Eur Arch Psychiatry ClinNeurosci 1:1–10

    Google Scholar 

  2. 2.

    Postuma RB et al (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142(3):744–759

    Article  Google Scholar 

  3. 3.

    Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. J Sleep Disord Res 3:7

    Google Scholar 

  4. 4.

    Barone DA, Henchcliffe C (2018) Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies. ClinNeurophysiol 129(8):1551–1564

    Google Scholar 

  5. 5.

    Ba M et al (2018) CSF Aβ 1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder. Trans Neurodegen 7(1):22

    Article  Google Scholar 

  6. 6.

    Ju Y-ES et al (2017) Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain 140(8):2104–2111

    Article  Google Scholar 

  7. 7.

    Postuma RB et al (2012) A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. MovDisord 27(7):913–916

    Google Scholar 

Download references


We hereby declare that we do not have acknowledgments to disclose. We also declare that our study has not received any sort of financial support.


We have received no funding for our study.

Author information



Corresponding author

Correspondence to Syeda Beenish Bareeqa.

Ethics declarations

Conflicts of interest

None to declare.

Ethics approval

Not applicable.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ahmed, S.I., Khalid, F., Bareeqa, S.B. et al. Alteration in cerebrospinal fluid (CSF) markers associated with α-synucleinopathies. Eur Arch Psychiatry Clin Neurosci (2020).

Download citation


  • Parkinson disease
  • Lewy body dementia
  • Cerebrospinal fluid
  • REM sleep behavior disorder